| 公開日 | 2021.08.03 |
| 計算日 | 2021.05.24 |
| 企業名 | 杏林製薬 |
| 空売り企業・個人名 | UBS AG |
| investment_contractor | |
| investment_fund | |
| 残高割合 | 0.27% |
| 増減率 | 0 % |
| 残高数量 | 175900 |
| 増減量 | |
| 前回計算日 | 03/15 |
| ステータス | 報告義務消失 |
| 備考 | There are errors in data of Ratio of Short Selling Positions to Shares Outstanding, Number of Short Selling Positions in Shares, and Number of Short Selling Positions in Trading Units in a report calculated on 2021/05/24, and we hereby corrected them as indicated on the left. (The data below are for before the correction.) Ratio of Short Selling Positions to Shares Outstanding: 0.51% Number of Short Selling in Shares: 331,500 Number of Short Selling in Trading Units: 3,315 |
| Previous ShortPosition ID |
| 空売り機関 | 公開日 | 計算日 | 増減率 | 残高数量 | 増減量 | 残高割合 |
|---|---|---|---|---|---|---|
| Wellington Management Company LLP on behalf of Hawkes Bay... | 2018-12-04 | 2018-11-30 | 0 % | 355,300 | 0.54% | |
| 計 | 355,300 | 計 | 0.54% | |||